Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;51(11):868-875.
doi: 10.1111/cup.14697. Epub 2024 Jul 30.

Primary cutaneous lymphoproliferations in the gray zone between marginal zone lymphoma and CD4+ small/medium T-cell lymphoproliferative disease

Kata Pálos  1 , József Szakonyi  2 , Judit Csomor  1 , Åsa Gremsperger  1 , Erik Zajta  1 , Márta Marschalkó  2 , Ágota Szepesi  1
Affiliations

Primary cutaneous lymphoproliferations in the gray zone between marginal zone lymphoma and CD4+ small/medium T-cell lymphoproliferative disease

Kata Pálos et al. J Cutan Pathol. 2024 Nov.

Abstract

Background: Primary cutaneous marginal zone lymphoma (PCMZL) and primary cutaneous CD4+ small/medium T-cell lymphoproliferative disease (CD4+ TLPD) are two distinct entities with excellent prognosis; however, they show profound clinical and histopathological similarities, leading to differential diagnostic uncertainty.

Aims: Our aim was to review and reanalyze cases of primary cutaneous lymphoproliferations diagnosed at Semmelweis University, featuring characteristics of PCMZL and CD4+ TLPD.

Materials and methods: Cutaneous lymphoma biopsy specimens between 2018 and 2022 were collected and re-evaluated. Medical history, clinical picture, imaging, and laboratory findings were collected. Immunohistochemical staining for CD20, CD3, BCL6, CD10, PD1, CD3, CD4, CD8, and PCR tests for IGH, IGK, TCRB, and TCRG were repeated in selected cases.

Results: Among 55 cases diagnosed as PCMZL (16) or CD4+ TLPD (39), 3 patients had been diagnosed with both LPDs at different time points of their disease course. Four additional patients were identified with single lesions featuring overlapping histopathological characteristics of both LPDs and both monoclonal IGH and TCR rearrangements. All patients are currently in complete remission with local treatment.

Conclusion: We propose that besides the overlapping histopathological, molecular, and clinical features, the subsequent appearance of PCMZL and CD4+ TLPD in a short timeframe in the same patients may suggest a common pathogenic background.

Keywords: PD1; helper T cells; lymphoid hyperplasia; primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disease; primary cutaneous marginal zone lymphoma; pseudo‐lymphoma.

PubMed Disclaimer

References

REFERENCES

    1. Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO‐EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703‐1714. doi:10.1182/blood‐2018‐11‐881268
    1. Robson A, Bakr F, Rashidghamat E, et al. Follicular T‐helper cells in marginal zone lymphoma: evidence of an organoid immune response. Am J Dermatopathol. 2021;43(12):e197‐e203.
    1. Egan C, Laurent C, Alejo JC, et al. Expansion of PD1‐positive T cells in nodal marginal zone lymphoma: a potential diagnostic pitfall. Am J Surg Pathol. 2020;44(5):657‐664.
    1. Cerroni L, Zöchling N, Pütz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B‐cell lymphoma. J Cutan Pathol. 1997;24(8):457‐461.
    1. Bakr F, Wain EM, Barlow R, Robson A. Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder or primary cutaneous marginal zone B‐cell lymphoma? Two distinct entities with overlapping histopathological features. Am J Dermatopathol. 2021;43(12):e204‐e212.

MeSH terms